Similar articles for PMID: 26040981

Year	Number of Results
2001	1
2002	3
2003	1
2004	1
2005	1
2006	2
2007	2
2008	6
2009	18
2010	16
2011	17
2012	20
2013	29
2014	31
2015	21
2016	17
2017	21
2018	23
2019	20
2020	26
2021	42
2022	31
2023	11
2024	0

1

Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Bayo P, Jou A, Stenzinger A, Shao C, Gross M, Jensen A, Grabe N, Mende CH, Rados PV, Debus J, Weichert W, Plinkert PK, Lichter P, Freier K, Hess J. Bayo P, et al. Mol Oncol. 2015 Oct;9(8):1704-19. doi: 10.1016/j.molonc.2015.05.006. Epub 2015 May 20. Mol Oncol. 2015. PMID: 26040981 Free PMC article.

2

Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.

Bochen F, Adisurya H, Wemmert S, Lerner C, Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, Bozzato A, Al Kadah B, Schick B, Linxweiler M. Bochen F, et al. Oncotarget. 2017 Jan 17;8(3):4922-4934. doi: 10.18632/oncotarget.13986. Oncotarget. 2017. PMID: 28002801 Free PMC article.

3

Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.

Thierauf J, Weissinger SE, Veit JA, Affolter A, Laureano NK, Beutner D, Heiduschka G, Kadletz L, Meyer M, Quaas A, Plinkert P, Hoffmann TK, Hess J. Thierauf J, et al. PLoS One. 2018 Mar 29;13(3):e0194989. doi: 10.1371/journal.pone.0194989. eCollection 2018. PLoS One. 2018. PMID: 29596469 Free PMC article.

4

Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.

Xiong HG, Li H, Xiao Y, Yang QC, Yang LL, Chen L, Bu LL, Zhang WF, Zhang JL, Sun ZJ. Xiong HG, et al. J Exp Clin Cancer Res. 2019 Jun 25;38(1):278. doi: 10.1186/s13046-019-1254-4. J Exp Clin Cancer Res. 2019. PMID: 31238980 Free PMC article.

5

Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.

Avincsal MO, Jimbo N, Fujikura K, Shinomiya H, Otsuki N, Morimoto K, Furukawa T, Morita N, Maehara R, Itoh T, Nibu KI, Zen Y. Avincsal MO, et al. Histopathology. 2018 Apr;72(5):826-837. doi: 10.1111/his.13436. Epub 2018 Jan 23. Histopathology. 2018. PMID: 29143365

6

Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.

Wu Y, Diao P, Li Z, Zhang W, Wang D, Wang Y, Cheng J. Wu Y, et al. J Oral Pathol Med. 2018 May;47(5):502-510. doi: 10.1111/jop.12708. Epub 2018 Apr 6. J Oral Pathol Med. 2018. PMID: 29569374

7

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.

Pavón MA, Arroyo-Solera I, Téllez-Gabriel M, León X, Virós D, López M, Gallardo A, Céspedes MV, Casanova I, López-Pousa A, Mangues MA, Quer M, Barnadas A, Mangues R. Pavón MA, et al. Oncotarget. 2015 Oct 6;6(30):29016-33. doi: 10.18632/oncotarget.5032. Oncotarget. 2015. PMID: 26359694 Free PMC article.

8

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma.

Baumeister P, Hollmann A, Kitz J, Afthonidou A, Simon F, Shakhtour J, Mack B, Kranz G, Libl D, Leu M, Schirmer MA, Canis M, Belka C, Zitzelsberger H, Ganswindt U, Hess J, Jakob M, Unger K, Gires O. Baumeister P, et al. Sci Rep. 2018 Oct 1;8(1):14582. doi: 10.1038/s41598-018-32178-8. Sci Rep. 2018. PMID: 30275505 Free PMC article.

9

Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.

Wolf GT, Winter W, Bellile E, Nguyen A, Donnelly CR, McHugh JB, Thomas D, Amlani L, Rozek L, Lei YL; Head and Neck SPORE Program. Wolf GT, et al. Oral Oncol. 2018 Dec;87:29-35. doi: 10.1016/j.oraloncology.2018.10.010. Epub 2018 Oct 22. Oral Oncol. 2018. PMID: 30527240 Free PMC article.

10

Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.

Khorani K, Schwaerzler J, Burkart S, Kurth I, Holzinger D, Flechtenmacher C, Plinkert PK, Zaoui K, Hess J. Khorani K, et al. Mol Cancer Res. 2021 Oct;19(10):1676-1687. doi: 10.1158/1541-7786.MCR-21-0066. Epub 2021 Jul 20. Mol Cancer Res. 2021. PMID: 34285085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

315 results

Results by year